#metabolic
Survodutide Research Peptide
10mg
Survodutide Research Peptide
10mg
Metabolic
Survodutide Research Peptide
Dual GLP-1/glucagon receptor agonist, 10mg vial
$140.00
This product is intended for in-vitro and pre-clinical research purposes only. It is not intended for human consumption, nor for use as a drug, food additive, or household chemical. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges all risks of handling and distribution, and agrees to indemnify Sokai Sciences against any claims arising from misuse.
FAQ
Common questions
What is Survodutide?+
A synthetic peptide engineered as a dual agonist at the GLP-1 and glucagon receptors.
Is Survodutide an approved medication?+
No — it's referenced in the literature as an investigational compound still in clinical trials.
What CAS number identifies Survodutide?+
2805997-46-8.
About
About Survodutide Research Peptide
Survodutide is a synthetic peptide engineered as a dual agonist at the GLP-1 and glucagon receptors, referenced in the published clinical-trial literature as an investigational compound still in late-stage development, not an approved medication. Third-party HPLC-verified purity (≥99% (HPLC)). For laboratory research use only.
More in Metabolic
You may also want
Metabolic
Prohibitin-targeting peptide conjugate (FTPP), 2mg vial
Lyophilized powder, vial · 2 sizes
Metabolic
Long-acting acylated amylin analog, 5mg vial
Lyophilized powder, vial · 2 sizes
Metabolic
Dual GLP-1/glucagon receptor agonist peptide, 5mg vial
Lyophilized powder, vial · 2 sizes